• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖缀合物:为疫苗开发掌握这些知名但知之甚少的免疫原需要什么。

Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development.

机构信息

Department of Biochemistry and Molecular Biology, Center for Molecular Medicine and Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.

GSK Vaccines, Siena, Italy.

出版信息

mSphere. 2019 Sep 25;4(5):e00520-19. doi: 10.1128/mSphere.00520-19.

DOI:10.1128/mSphere.00520-19
PMID:31554723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6763769/
Abstract

Glycoconjugate vaccines are a critical component of the medical arsenal against infectious diseases. This established field continues, however, to experience failures in the clinic. The lack of fundamental understanding of factors controlling clinical efficacy of glycoconjugate vaccines is discussed while key parameters demanding focused and collaborative research are identified.

摘要

糖缀合物疫苗是对抗传染病的医学武器库中的重要组成部分。然而,这一成熟领域在临床应用中仍不断遭遇失败。本文讨论了缺乏对控制糖缀合物疫苗临床疗效的因素的基本认识,并确定了需要重点关注和协作研究的关键参数。

相似文献

1
Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development.糖缀合物:为疫苗开发掌握这些知名但知之甚少的免疫原需要什么。
mSphere. 2019 Sep 25;4(5):e00520-19. doi: 10.1128/mSphere.00520-19.
2
Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.提高糖缀合物疫苗的效力:从化学缀合物到下一代构建体。
Curr Opin Immunol. 2020 Aug;65:42-49. doi: 10.1016/j.coi.2020.03.015. Epub 2020 Apr 30.
3
Synthetic carbohydrate-based vaccines: challenges and opportunities.合成碳水化合物疫苗:挑战与机遇。
J Biomed Sci. 2020 Jan 3;27(1):9. doi: 10.1186/s12929-019-0591-0.
4
[Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].[碳水化合物与疫苗:从纯化多糖到半合成糖缀合物疫苗]
Ann Pharm Fr. 2007 Jan;65(1):14-32. doi: 10.1016/s0003-4509(07)90014-0.
5
Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design.细菌蛋白聚糖偶联技术和糖缀合物疫苗设计的最新进展。
J Med Microbiol. 2012 Jul;61(Pt 7):919-926. doi: 10.1099/jmm.0.039438-0. Epub 2012 Apr 19.
6
Glycoconjugate vaccines: future combinations.糖缀合物疫苗:未来的联合应用
Dev Biol Stand. 1996;87:269-75.
7
Glycoconjugate vaccines: classic and novel approaches.糖缀合物疫苗:经典与新型方法。
Glycoconj J. 2021 Aug;38(4):397-398. doi: 10.1007/s10719-021-09997-5. Epub 2021 Jun 25.
8
Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production.改进糖基化蛋白偶联技术(PGCT)用于糖缀合物疫苗生产。
Expert Rev Vaccines. 2020 Jun;19(6):507-527. doi: 10.1080/14760584.2020.1775077. Epub 2020 Jul 5.
9
Glycoconjugate vaccines: Principles and mechanisms.糖缀合物疫苗:原理与机制。
Sci Transl Med. 2018 Aug 29;10(456). doi: 10.1126/scitranslmed.aat4615.
10
Glycoconjugate vaccines: current approaches towards faster vaccine design.糖缀合物疫苗:更快疫苗设计的当前方法。
Expert Rev Vaccines. 2019 Sep;18(9):881-895. doi: 10.1080/14760584.2019.1657012. Epub 2019 Aug 31.

引用本文的文献

1
Synthesis and Immunogenicity of Pseudo-Oligosaccharides Structurally Related to Repeating Units of Capsular Phosphoglycans of Human Pathogens.与人病原体荚膜磷酸聚糖重复单元结构相关的假寡糖的合成及免疫原性
Molecules. 2025 Jul 22;30(15):3068. doi: 10.3390/molecules30153068.
2
A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model.一种基于佐剂和铁蛋白纳米笼的联合粘膜疫苗可在小鼠模型中诱导针对肺炎链球菌的保护性免疫反应。
Nat Commun. 2025 Mar 24;16(1):2871. doi: 10.1038/s41467-025-58115-8.
3
Identification and Characterization of the Two Glycosyltransferases Required for the Polymerization of the HS:1 Serotype Capsular Polysaccharide of G1.

本文引用的文献

1
A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.一种新型六价荚膜多糖结合疫苗(GBS6),通过母体免疫预防新生儿 B 型链球菌感染。
J Infect Dis. 2019 Jun 5;220(1):105-115. doi: 10.1093/infdis/jiz062.
2
On the mechanisms of conjugate vaccines.论结合疫苗的作用机制。
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):14-16. doi: 10.1073/pnas.1819612116. Epub 2018 Dec 21.
3
Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
G1型HS:1血清型荚膜多糖聚合所需的两种糖基转移酶的鉴定与表征
Biochemistry. 2025 Mar 18;64(6):1370-1379. doi: 10.1021/acs.biochem.4c00803. Epub 2025 Feb 28.
4
Further Insights into the Measurement of Free Polysaccharide in Meningococcal Conjugate Vaccines.对脑膜炎球菌结合疫苗中游离多糖测量的进一步见解。
Vaccines (Basel). 2025 Feb 9;13(2):167. doi: 10.3390/vaccines13020167.
5
Pilus of : structure, function and vaccine potential.菌毛:结构、功能与疫苗潜力。
Front Cell Infect Microbiol. 2023 Sep 20;13:1270848. doi: 10.3389/fcimb.2023.1270848. eCollection 2023.
6
Emerging vaccine strategies against the incessant pneumococcal disease.针对持续性肺炎球菌疾病的新型疫苗策略
NPJ Vaccines. 2023 Aug 17;8(1):122. doi: 10.1038/s41541-023-00715-w.
7
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections.近年来,针对铜绿假单胞菌感染的治疗靶点的鉴定和治疗策略的发展取得了进展。
BMC Microbiol. 2023 Mar 30;23(1):86. doi: 10.1186/s12866-023-02832-x.
8
Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models.优化双价多糖结合物的制备工艺,开发针对肺炎链球菌或脑膜炎奈瑟菌的多价结合疫苗,并与动物模型中相应的已许可疫苗进行比较。
Curr Med Sci. 2023 Feb;43(1):22-34. doi: 10.1007/s11596-022-2652-y. Epub 2023 Jan 21.
9
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods.肺炎球菌糖共轭疫苗的共轭机制:经典方法与新出现的方法
Bioengineering (Basel). 2022 Dec 6;9(12):774. doi: 10.3390/bioengineering9120774.
10
Synthetic Zwitterionic Streptococcus pneumoniae Type 1 Oligosaccharides Carrying Labile O-Acetyl Esters.带有不稳定 O-乙酰酯的合成两性离子肺炎链球菌 1 型寡糖。
Angew Chem Int Ed Engl. 2023 Jan 2;62(1):e202211940. doi: 10.1002/anie.202211940. Epub 2022 Dec 1.
多糖结构决定了糖缀合物疫苗对适应性免疫反应的机制。
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):193-198. doi: 10.1073/pnas.1816401115. Epub 2018 Dec 3.
4
Glycoconjugate vaccines: Principles and mechanisms.糖缀合物疫苗:原理与机制。
Sci Transl Med. 2018 Aug 29;10(456). doi: 10.1126/scitranslmed.aat4615.
5
Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.O-乙酰化在细菌多糖疫苗免疫原性中的作用。
Molecules. 2018 Jun 2;23(6):1340. doi: 10.3390/molecules23061340.
6
Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.疟疾来源的糖基磷脂酰肌醇锚增强了可阻断疟疾传播的抗Pfs25功能性抗体。
Biochemistry. 2018 Feb 6;57(5):516-519. doi: 10.1021/acs.biochem.7b01099. Epub 2018 Jan 16.
7
Semisynthetic glycoconjugate vaccine candidate against serotype 5.针对 5 型的半合成糖缀合物疫苗候选物。
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11063-11068. doi: 10.1073/pnas.1706875114. Epub 2017 Oct 2.
8
T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of .针对[具体病原体]3型荚膜多糖的T细胞介导的体液免疫反应 。 你提供的原文中“.”部分缺失具体内容,请补充完整以便更准确翻译。
J Immunol. 2017 Jul 15;199(2):598-603. doi: 10.4049/jimmunol.1700026. Epub 2017 May 31.
9
Structure of a protective epitope of group B type III capsular polysaccharide.B族Ⅲ型荚膜多糖保护性表位的结构
Proc Natl Acad Sci U S A. 2017 May 9;114(19):5017-5022. doi: 10.1073/pnas.1701885114. Epub 2017 Apr 24.
10
Factors contributing to the immunogenicity of meningococcal conjugate vaccines.导致脑膜炎球菌结合疫苗免疫原性的因素。
Hum Vaccin Immunother. 2016 Jul 2;12(7):1808-24. doi: 10.1080/21645515.2016.1153206. Epub 2016 Mar 2.